Sachin Parenteral Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.83 Cr
- Revenue Growth 145.59%
- Profit Growth 120.16%
- Ebitda 79.18%
- Net Worth 94.02%
- Total Assets 37.85%
About Sachin Parenteral
Sachin Parenteral Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 February 2017 (Eight years 13 days old ). Its registered office is in Aligarh, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.83 Cr.
Sachin Maheshwari and Sanjay Maheshwari serve as directors at the Company.
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304UP2017PTC090294
- Company No.
090294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Sachin Parenteral?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Maheshwari  | Director | 10-Feb-2017 | Current |
| Sanjay Maheshwari | Director | 10-Feb-2017 | Current |
Financial Performance of Sachin Parenteral.
Sachin Parenteral Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 145.59% increase. The company also saw a substantial improvement in profitability, with a 120.16% increase in profit. The company's net worth Soared by an impressive increase of 94.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sachin Parenteral?
In 2023, Sachin Parenteral had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swaroop Pharmaceuticals Private LimitedSanjay Maheshwari is a mutual person
Biosynergy Healthcare Private LimitedSachin Maheshwari is a mutual person
- Biosynergy Lifecare Private Limited
Sachin Maheshwari is a mutual person
- Mishka Exports Private Limited
Sachin Maheshwari is a mutual person
- Collab Packaging Private Limited
Sachin Maheshwari is a mutual person
- Rawat Multispecialitycenter Private Limited
Sachin Maheshwari is a mutual person
Charges (Loans)
₹8.83 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 8.83 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2022 | Others | ₹3.50 M | Open |
| 17 Mar 2021 | Others | ₹8.48 Cr | Open |
How Many Employees Work at Sachin Parenteral?
Unlock and access historical data on people associated with Sachin Parenteral, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sachin Parenteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sachin Parenteral's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.